Home / Where We Work / RTSL: India
RTSL: India
Resolve to Save Lives’ New Delhi office opened its doors in 2024 to serve our longstanding partnerships for cardiovascular health in India.

Resolve to Save Lives is committed to supporting the Government of India in achieving United Nations Sustainable Development Goal 3.4. To strengthen hypertension treatment and control under the National Program for Prevention & Control of NCDs (NP-NCD), RTSL launched the award-winning India Hypertension Control Initiative (IHCI) in 2017 in collaboration with the Ministry of Health and Family Welfare, state governments, the Indian Council of Medical Research, and the World Health Organization (WHO). In just a few short years, IHCI grew to provide quality care to millions of patients with hypertension and diabetes. With IHCI strategies now successfully integrated into the National Program, we continue to work with the Government and partners to strengthen primary health care for hypertension and diabetes control.
We also focus on promoting healthier diets to improve heart health in India, with an emphasis on sodium reduction to support the Government of India’s goal of a 30% reduction in salt intake at the population level. Our key areas of work include supporting interventions like replacing edible salt with low-sodium substitutes in households, implementing healthy food procurement policies in schools and other public settings, and supporting the government in reducing the consumption of processed and packaged foods through interventions like front-of-pack labelling, fiscal measures, and marketing restrictions on unhealthy foods, all aimed at fostering a healthier food environment.
Our Programs

In 2021, India became the first low- to middle-income country to join our global movement to eliminate trans fat from the food supply by adopting WHO’s REPLACE action package, developed and implemented with RTSL’s technical expertise. Our support for trans fat elimination in India continues through efforts to strengthen laboratories for effective monitoring and enforcement, as well as by advancing research on healthier replacement options.
Our Partners in India
- Ministry of Health and Family Welfare (MoHFW)
- Indian Council of Medical Research (ICMR)
- National Health Systems Resource Centre (NHSRC)
- Food Safety and Standards Authority of India (FSSAI)
- National Institute of Nutrition (NIN)
- World Health Organization (WHO)
- Global Health Advocacy Incubator
- WISH Foundation
- IPE Global

News from India
Resources
A quality improvement (QI) initiative conducted by the India Hypertension Control Initiative (IHCI) between January 2021 and September 2022 led to an increase in monthly follow-up visits from 21% to 37% and a decrease in missed health visits from 66% to 22%. Of the individuals counseled by ASHA home visits, 74.9% returned for follow-up. The QI initiative organized a multidisciplinary team to identify major root causes for missed visits—such as not effectively mobilizing patients for follow-up visits— and develop countermeasures—such as improved tracking as use of ASHA home visits. Health care workers were trained in the interventions, and a simple, digital health tool captured real-time data to follow progress of interventions in monthly data review meetings once they were implemented.
ABSTRACT
Background In India, to achieve a 25% relative reduction in the prevalence of raised blood pressure (BP) by 2025, approximately 4.5 crore additional people with hypertension will need to have their BP effectively treated. We conducted a Quality Improvement (QI) initiative to improve follow- up and reduce missed visits among individuals with hypertension registered under India Hypertension Control Initiative, District Hospital, Seoni, Madhya Pradesh, India, in 2022.
A recent analysis authored by RTSL and our partners in India shows a lack of awareness among private sector providers in India that high blood pressure is a critical health threat. Providing prescriptions to patients is the first step in increasing medication availability and affordability. To encourage evidence-based hypertension care, the government and NGOs could implement strategies such as tailored incentives, financial rewards, tax benefits, accreditation, and recognition for private healthcare providers who prioritize controlling high blood pressure. Professional bodies in the private sector should establish programs emphasizing quality assurance and certifications in this area. Future research should focus on designing and testing new models for private sector hypertension service delivery.
Can 7-1-7 help household contacts of tuberculosis patients get started on preventive therapy? In the International Journal of Tuberculosis and Lung Disease, our colleagues at International Union Against Tuberculosis and Lung Disease used a mixed-methods approach to assess the feasibility of the timeliness metric in the private sector in Chennai, India. Among 263 index patients, 90% had their household contacts (HHCs) line-listed within 7 days. Screening outcomes for 48% of the 556 were achieved in HHCs within 1 day, and 57% began TPT or received a treatment decision within 7 days. 24% of screened HHCs started TPT during the ‘7-1-7’ period, compared to 16% in historical controls. Barriers included HHC reluctance to be evaluated, private providers’ refusal to prescribe TPT, and reliance on facility-based screening instead of home visits. Overall, the introduction of 7-1-7 can effectively enhance HHC screening and management.
Contact us
Resolve To Save Lives Services
Private Limited Regus,
4th Floor, Rectangle No 1,
Commercial Complex D4, Saket,
New Delhi-110017, India
Phone | 01166544051 |
CIN | U82990DL2023FTC422985 |
[email protected] |